Friday, November 13, 2026

AI Research

5 articles

AI Solves Complex Math Problems in Hours on Single Machines, Reshaping Global Research Access

AI Solves Complex Math Problems in Hours on Single Machines, Reshaping Global Research Access

Axiom Math's Axplorer solves complex mathematical problems in hours on standard computers, democratizing capabilities previously locked behind institutional gates like DeepMind's AlphaEvolve. OpenAI builds AI systems functioning as automated research interns, with Chief Scientist Jakub Pachocki projecting transformative impact before 2028 despite systems not matching human intelligence across all dimensions. The shift creates a two-tier global market between open tools and closed institutional s

LM Salvado•
OpenAI Chief Scientist Predicts Autonomous AI Research Labs Operating Without Human Oversight

OpenAI Chief Scientist Predicts Autonomous AI Research Labs Operating Without Human Oversight

OpenAI chief scientist Jakub Pachocki says AI systems will soon run entire research labs autonomously in data centers, working indefinitely without human intervention. The prediction comes as global AI infrastructure markets split between high-end training hardware and efficiency-focused inference systems. Regulatory frameworks lag behind technical capabilities, with deployment safety concerns unresolved across jurisdictions.

LM Salvado•
OpenAI Scientist: Autonomous AI Research Labs Arriving Within Months

OpenAI Scientist: Autonomous AI Research Labs Arriving Within Months

OpenAI's chief scientist Jakub Pachocki says models capable of working indefinitely without human supervision are months away, not years. The shift from AI assistants to autonomous researchers could compress development cycles while concentrating technological power in companies operating large data centers. Governments worldwide lack frameworks to oversee AI systems conducting independent research beyond human supervision timescales.

LM Salvado•
OpenAI Scientist Envisions Autonomous Research Labs Operating in Data Centers for Months

OpenAI Scientist Envisions Autonomous Research Labs Operating in Data Centers for Months

OpenAI Chief Scientist Jakub Pachocki predicts AI models will soon conduct research autonomously for extended periods, functioning as "a whole research lab in a data center." The development raises governance challenges as 68 AI infrastructure companies reached unicorn status in early 2026, concentrating research capacity among organizations with massive computational resources.

LM Salvado•
OpenAI Targets Fully Autonomous AI Research Labs That Run Without Human Scientists

OpenAI Targets Fully Autonomous AI Research Labs That Run Without Human Scientists

OpenAI plans to build AI systems capable of conducting research indefinitely without human supervision, with Chief Research Officer Jakub Pachocki envisioning entire research labs operating autonomously in data centers. The shift toward automated research interns raises governance challenges governments have yet to address as AI capabilities concentrate among few global organizations.

LM Salvado•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com